{"id":"W4400937723","doi":"10.1016/s0140-6736(24)01203-0","title":"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials","year":2024,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"Galderma","keywords":"Arcadia; Medicine; Atopic dermatitis; Concomitant; Dermatology; Double blind; Randomized controlled trial; Pediatrics; Internal medicine; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002064517,0.001069568,0.003768187,0.0003886915,0.0003626841,0.0009990466,0.0007996868,0.001843052,0.003365353],"category_scores_gemma":[0.002001832,0.0006165475,0.00273654,0.0004288627,0.0009881792,0.001134144,0.0003927654,0.002760464,0.000491492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005604783,"about_ca_system_score_gemma":0.0006808521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001051555,"about_ca_topic_score_gemma":0.002857777,"domain_scores_codex":[0.9990926,0.0004617026,0.00009888624,0.0001521851,0.00009051157,0.0001042049],"domain_scores_gemma":[0.9991319,0.0003091179,0.0002491402,0.00005730258,0.0000492971,0.0002032066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9563456,0.003081761,0.00112532,0.003121628,0.003701748,0.00007094955,0.0001246997,0.0001632044,0.00353999,0.00009164591,0.0005789698,0.02805449],"study_design_scores_gemma":[0.9492004,0.04380526,0.004153839,0.0001452077,0.001415002,0.00005949064,0.00004784025,0.0001342729,0.0002764867,0.00009241108,0.0006551799,0.00001466674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.957786,0.03654924,0.000564498,0.0005884456,0.0005721424,0.001706163,0.0005719214,0.00007514213,0.001586459],"genre_scores_gemma":[0.9811567,0.01270429,0.001229658,0.0008109215,0.0004017432,0.001689171,0.0005231352,0.00001561703,0.001468692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003768187,"threshold_uncertainty_score":0.0112583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04284180332162156,"score_gpt":0.3310487587940612,"score_spread":0.2882069554724396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}